Updated:
Tri-Star Technology
TriStar accelerates oncology R&D with quality biospecimens and data. Its biospecimen repository is purpose-built to accelerate oncology therapeutic...
Tri-Star Technology
TriStar accelerates oncology R&D with quality biospecimens and data. Its biospecimen repository is purpose-built to accelerate oncology therapeutic development, serving pharma, biotech, diagnostics, and AI companies. Offerings include ethically approved anonymized clinical samples with annotated data, tissue microarrays, FFPE blocks, and integrated biomarker services such as IHC, RNAScope, NGS, and digital spatial profiling.
General information
Firm type
Private Equity
Location
Region
North America
Country
United States
City
Nashville
Corporate office
Nashville, TN, United States
Sector focus
Frequently asked questions
Which investment stages does Tri-Star Technology target?
The firm focuses on early-stage technology investments, specifically seed rounds and start-up phases. Capital is deployed at the point of company formation or initial growth. This places Tri-Star at the earliest point in the private equity lifecycle.
What is Tri-Star Technology's geographic investment focus?
The firm is headquartered in Nashville, Tennessee, and directs its investment activity toward technology ventures in the United States. Nashville's emerging tech ecosystem provides an operating base distinct from traditional coastal venture hubs.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: